397 related articles for article (PubMed ID: 9717055)
21. Secondary endothelial dysfunction: hypertension and heart failure.
Boulanger CM
J Mol Cell Cardiol; 1999 Jan; 31(1):39-49. PubMed ID: 10072714
[TBL] [Abstract][Full Text] [Related]
22. Enhanced angiotensin-converting enzyme activity and impaired endothelium-dependent vasodilation in aortae from hypertensive rats: evidence for a causal link.
Goetz RM; Holtz J
Clin Sci (Lond); 1999 Aug; 97(2):165-74. PubMed ID: 10409471
[TBL] [Abstract][Full Text] [Related]
23. [Role of endothelial nitric oxide in the regulation of arterial tone].
Michel JB
Rev Prat; 1997 Dec; 47(20):2251-6. PubMed ID: 9616914
[TBL] [Abstract][Full Text] [Related]
24. Ramipril improves nitric oxide availability in hypertensive rats with failing hearts after myocardial infarction.
Linz W; Itter G; Dobrucki LW; Malinski T; Wiemer G
J Renin Angiotensin Aldosterone Syst; 2003 Sep; 4(3):180-5. PubMed ID: 14608524
[TBL] [Abstract][Full Text] [Related]
25. Improvement of endothelial function by chronic angiotensin-converting enzyme inhibition in heart failure : role of nitric oxide, prostanoids, oxidant stress, and bradykinin.
Varin R; Mulder P; Tamion F; Richard V; Henry JP; Lallemand F; Lerebours G; Thuillez C
Circulation; 2000 Jul; 102(3):351-6. PubMed ID: 10899101
[TBL] [Abstract][Full Text] [Related]
26. Addition of spironolactone to angiotensin-converting enzyme inhibition in heart failure improves endothelial vasomotor dysfunction: role of vascular superoxide anion formation and endothelial nitric oxide synthase expression.
Bauersachs J; Heck M; Fraccarollo D; Hildemann SK; Ertl G; Wehling M; Christ M
J Am Coll Cardiol; 2002 Jan; 39(2):351-8. PubMed ID: 11788231
[TBL] [Abstract][Full Text] [Related]
27. Chronic infusion of bradykinin delays the progression of heart failure and preserves vascular endothelium-mediated vasodilation in conscious dogs.
Tonduangu D; Hittinger L; Ghaleh B; Le Corvoisier P; Sambin L; Champagne S; Badoual T; Vincent F; Berdeaux A; Crozatier B; Su JB
Circulation; 2004 Jan; 109(1):114-9. PubMed ID: 14662711
[TBL] [Abstract][Full Text] [Related]
28. Kinin-mediated coronary nitric oxide production contributes to the therapeutic action of angiotensin-converting enzyme and neutral endopeptidase inhibitors and amlodipine in the treatment in heart failure.
Zhang X; Recchia FA; Bernstein R; Xu X; Nasjletti A; Hintze TH
J Pharmacol Exp Ther; 1999 Feb; 288(2):742-51. PubMed ID: 9918584
[TBL] [Abstract][Full Text] [Related]
29. Nitric oxide production and NO synthase gene expression contribute to vascular regulation during exercise.
Shen W; Zhang X; Zhao G; Wolin MS; Sessa W; Hintze TH
Med Sci Sports Exerc; 1995 Aug; 27(8):1125-34. PubMed ID: 7476056
[TBL] [Abstract][Full Text] [Related]
30. Angiotensin II-induced vasodilation via type 2 receptor: role of bradykinin and nitric oxide.
Yayama K; Okamoto H
Int Immunopharmacol; 2008 Feb; 8(2):312-8. PubMed ID: 18182246
[TBL] [Abstract][Full Text] [Related]
31. Endothelium-dependent responses in congestive heart failure.
Vanhoutte PM
J Mol Cell Cardiol; 1996 Nov; 28(11):2233-40. PubMed ID: 8938576
[TBL] [Abstract][Full Text] [Related]
32. Impaired bradykinin response to ischaemia and exercise in patients with mild congestive heart failure during angiotensin-converting enzyme treatment. Relationships with endothelial function, coagulation and inflammation.
Cugno M; Agostoni P; Mari D; Meroni PL; Gregorini L; Bussotti M; Anguissola GB; Donatelli F; Nussberger J
Br J Haematol; 2005 Jul; 130(1):113-20. PubMed ID: 15982353
[TBL] [Abstract][Full Text] [Related]
33. Regulation of coronary blood flow during exercise.
Duncker DJ; Bache RJ
Physiol Rev; 2008 Jul; 88(3):1009-86. PubMed ID: 18626066
[TBL] [Abstract][Full Text] [Related]
34. Bradykinin as a major endogenous regulator of endothelial function.
Gryglewski RJ; Uracz W; Chłopicki S; Marcinkiewicz E
Pediatr Pathol Mol Med; 2002; 21(3):279-90. PubMed ID: 12056503
[TBL] [Abstract][Full Text] [Related]
35. Endothelial control of vascular tone in chronic heart failure.
Kiowski W; Sütsch G; Schalcher C; Brunner HP; Oechslin E
J Cardiovasc Pharmacol; 1998; 32 Suppl 3():S67-73. PubMed ID: 9883751
[TBL] [Abstract][Full Text] [Related]
36. Primary endothelial dysfunction: atherosclerosis.
Shimokawa H
J Mol Cell Cardiol; 1999 Jan; 31(1):23-37. PubMed ID: 10072713
[TBL] [Abstract][Full Text] [Related]
37. Quinapril demonstrates improved endothelium-mediated vasodilation in patients with chronic heart failure.
Compr Ther; 1998 Jan; 24(1):38. PubMed ID: 9452901
[No Abstract] [Full Text] [Related]
38. ACE inhibition with perindopril and endothelial function. Results of a substudy of the EUROPA study: PERTINENT.
Ceconi C; Fox KM; Remme WJ; Simoons ML; Bertrand M; Parrinello G; Kluft C; Blann A; Cokkinos D; Ferrari R; ;
Cardiovasc Res; 2007 Jan; 73(1):237-46. PubMed ID: 17140552
[TBL] [Abstract][Full Text] [Related]
39. Tetrahydrobiopterin and endothelial function.
Cosentino F; Lüscher TF
Eur Heart J; 1998 Jul; 19 Suppl G():G3-8. PubMed ID: 9717048
[TBL] [Abstract][Full Text] [Related]
40. ACE inhibition, endothelial function and coronary artery lesions. Role of kinins and nitric oxide.
Mombouli JV
Drugs; 1997; 54 Suppl 5():12-22. PubMed ID: 9429841
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
